Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain

This publication has 14 references indexed in Scilit:

• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome
  Menopause, 2002
• The Effect of Androstenedione/Estrone Supplementation on Cortical and Cancellous Bone in the Young Intact Female Monkey: A Model for the Effects of Polycystic Ovarian Disease on the Skeleton?
  Osteoporosis International, 2000
• Estrogen with interrupted progestin HRT: a review of experimental and clinical studies
  Maturitas, 2000
• Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin- releasing hormone agonist
  Fertility and Sterility, 1998
• GnRH agonists and add‐back therapy: is there a perfect combination?
  BJOG: An International Journal of Obstetrics and Gynaecology, 1998
• Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment
  Fertility and Sterility, 1996
• The effect of three hormone replacement regimens on bone density in the aged ovariectomized rat
  Fertility and Sterility, 1995
• Prevalence and genesis of endometriosis
  Human Reproduction, 1991
• Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy
  American Journal of Obstetrics and Gynecology, 1990